3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase 2
2
Phase 3
1
Phase 1/2
1
Status
Completed
5
Unknown
1
Terminated
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Cisplatin
130
Radiotherapy
94
Carboplatin
85
Fluorouracil
79
Paclitaxel
78
Cyclophosphamide
77
Gemcitabine
72
Capecitabine
66
Docetaxel
65
Doxorubicin
60
Oxaliplatin
59
Etoposide
57
Leucovorin
50
Vincristine
47
Chemotherapy, Adjuvant
42
Cytarabine
38
Dexamethasone
35
Drug Therapy
33
Bevacizumab
31
Epirubicin
29
Neoadjuvant Therapy
28
Pemetrexed
27
Tamoxifen
25
Irinotecan
25
Prednisone
24
Rituximab
21
Methotrexate
21
Radiotherapy, Intensity-Modulated
19
apatinib
18
Vinorelbine
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Unknown
×
peginterferon alfa-2a
×
Clear all
NCT02381379
2020-09-14
MSIT
Ministry of Health, Malaysia
Phase 3
Unknown
118 enrolled